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Metabolic Syndrome (MetS), a constellation of risk factors including 
dyslipidemia, hypertension, central adiposity, and impaired fasting glucose, is increasing 
at an alarming rate in the United States (1,2). It is estimated that over 47 million 
Americans meet the criteria for the metabolic syndrome (3). Current statistics reveal 26.8 
percent of adult Oklahomans are categorized as obese (body mass index >30), with 
Oklahoma ranking as the ninth most obese state in the country (4). Overweight and 
obesity are positively correlated with the incidence of type 2 diabetes, high blood 
pressure, asthma, arthritis, and overall poor health status (5). To combat obesity, 
Americans seek alternative strategies, such as nonprescription dietary supplements (6), 
fad diets (7), holistic approaches, and phytotherapy involving soy (8) and supplements 
such as green tea (9). Although it is an ideal practice to increase physical activity and 
adopt healthy eating habits to prevent obesity, keeping in view their increasing use, 
alternative nutritional therapies for better health must be investigated.  
 
Green Tea and Composition 
 Green tea, or non-fermented tea, is rich in polyphenolic flavonoids, primarily 
catechins. Although processing and preparation affect the catechin content of green tea 
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leaves, epigallocatechin gallate (EGCG) is generally the most abundant catechin (49-
55%), followed by epigallocatechin (EGC) (9-12%), epicatechin gallate (ECG) (9-12%) 
and epicatechin (EC) (5-7%) (10).  Recently reported data from the Ohsaki study, which 
included 40,530 Japanese adults who were followed up for up to 11 years (1995-2005), 
showed an inverse association between green tea consumption and mortality due to all 
causes and cardiovascular disease (11). Habitual green tea intake of 120 mL or more per 
day for 1 year was significantly correlated with a risk reduction of developing 
hypertension in Chinese population, compared to nonhabitual tea drinkers (12). Most of 
these observational studies have been conducted in China and Japan where green tea is 
part of traditional diet, in contrast to western countries where it is limited and sporadic. 
 
Role of Green Tea in Human Subjects and Animal Models 
 Green tea, or its active compound EGCG, has been widely used in weight loss 
diets, and has been shown to reduce adipocyte differentiation and proliferation, 
lipogenesis, fat mass and body weight, and to increase beta-oxidation and thermogenesis 
(13). In vitro studies with EGCG have also shown a direct inhibition of gastric and 
pancreatic lipases and stimulation of thermogenesis, via inhibition of enzymatic 
degradation of noradrenalin, thus suggesting the mechanisms underlying these effects 
(14). While limited clinical trials have shown the anti-obesity effects of green tea extracts 
or EGCG (15-17), its effects on body weight and body fat composition in subjects with 
MetS needs further investigation. 
Green tea has also been shown to affect lipid and glucose metabolism in rodents 
(19, 20) and in blood pressure in normotensive men (21). Murase and colleagues (18) 
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tested the effects of green tea catechins, on diet-induced obese mice over 11 months. 
Catechin supplementation (0.2 and 0.5% w/w) reduced the high-fat diet-induced body 
weight gain, visceral and liver fat accumulation, and the development of 
hyperinsulinemia, and hyperleptinemia, when compared to mice consuming high-fat diets 
without catechin supplementation. These data suggest that long-term consumption of tea 
catechins may be beneficial to counteract diet-induced obesity and obesity-related 
complications in humans.   
Administration of 130mg of powdered green tea per day in male Zucker rats, fed 
a high-fat diet containing 15% butter and 50% sucrose, was also shown to produce 
hypocholesterolemic effects as well as a decrease in body weight gain and adiposity (19). 
EGCG administration was also shown to exert antidiabetic effects and down-regulate 
genes involved in gluconeogenesis, and the synthesis of fatty acids, triacylglycerol and 
cholesterol in rodents (20).  
While studying the effects of green tea on blood pressure, Hodgson et al. (21) 
rejected their initial hypothesis that tea consumption (caffeinated) would cause a decrease 
in blood pressure in normotensive men. An acute increase in blood pressure with green 
and black tea (4 cups) versus caffeine alone was noted.  The study also examined the 
effects of green and black tea consumption (5 cups/day for 7 days) on 24 hour 
ambulatory blood pressure versus caffeine alone, and no significant changes were 
detected. Additional research is needed to determine the effects of decaffeinated green tea 







Since most of the current research on health benefits of green tea and EGCG has 
been performed in animal models, in Asian populations and healthy overweight subjects, 
there exists a need for investigation in “at risk” US adults, consuming a typical western 
diet. Thus, the purpose of this 2-month study was to compare the effects of decaffeinated 
green tea beverage and EGCG supplementation on body weight, body fat composition, 
blood pressure, blood glucose, and lipid levels in subjects with MetS in urban Oklahoma. 
We also aimed to study any differences on these variables of interest as a result of 
catechin supplementation from green tea beverage versus green tea extract containing 
EGCG, thus addressing the research gap between whole food versus dietary supplement.  
 
Hypotheses 
1) Daily consumption of green tea beverage or EGCG supplements will have no 
significant effect on anthropometric measures in participants with MetS. 
2) Daily consumption of green tea beverage or EGCG supplements will have no 
significant effect on glucose and lipid parameters in participants with MetS. 
3) Daily consumption of green tea beverage or EGCG supplements will have no 





REVIEW OF LITERATURE 
 
There exists a need for alternative methods to improve lipid levels in the blood, 
central adiposity, blood pressure and blood glucose levels, factors intertwined in the 
definition of MetS.  
 
Metabolic Syndrome (MetS) 
Although the underlying idea of MetS was identified as early as 1923 by Kylin 
(22) and in 1988 by Reaven (23), the term was not introduced until 2001 by the National 
Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III). The term, 
metabolic syndrome, was coined in response to the increased prevalence of obesity in the 
United States. According to NCEP ATP III, a person may be classified with this 
syndrome if three or more of the following features are present: waist circumference >40 
inches in men and >35 inches in women, triglycerides >150 mg/dl or drug treatment for 
elevated triglycerides, high-density lipoprotein cholesterol (HDL-C) <40 mg/dl in men 
and <50 mg/dl in women or treatment for HDL-C, systolic blood pressure (SBP) >130 
mmHg or diastolic blood pressure (DBP) >85 mmHg or drug treatment for hypertension, 
and fasting glucose >100 mg/dl or drug treatment for elevated glucose (24).
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Since first introduced, the definition of MetS has caused controversy among 
different scientific realms, such as the World Health Organization (WHO) and ATP III. 
Grundy (2006) stated the classification of MetS as a means to unify the cardiovascular 
and diabetes worlds in an effort to decrease the risks associated with both conditions. The 
risk of development of atherosclerotic cardiovascular disease (CVD) and diabetes is 
increased when MetS is identified (1). Isomaa et al. (25) utilized the definition proposed 
by WHO (different than ATP III guidelines) to analyze the cardiovascular risk associated 
with MetS of subjects (n=4,483) participating in the Botnia Study. The components used 
to define MetS included hypertension (systolic >150 mmHg or diastolic >90 mmHg) or 
anti-hypertensive treatment, dyslipidemia (plasma triglyceride >1.7 mmol/l and/or HDL 
<0.9 mmol/l in men, <1.0 mmol/l in women, obesity (body mass index (BMI) >30 kg/m
2
 
and/or waist-to-hip ratio of >0.9 in men and >0.85 in women), and microalbuminuria 
(urinary albumin excretion rate (AER) >20 µg/min).  The subjects were given an oral 
glucose tolerance test (OGTT), and were categorized based on those results: normal 
glucose tolerance (NGT), impaired fasting glucose/impaired glucose tolerance 
(IFG/IGT), and type 2 diabetes. The three groups were defined as follows: NGT, fasting 
plasma glucose <6.1 mmol/l and 2-h plasma glucose <7.8 mmol/l, IFG/IGT, fasting 
plasma glucose 6.1-6.9 mmol/l and/or 2-h plasma glucose 7.8-11.0 mmol/l, and type 2 
diabetes, fasting plasma glucose > 7.0 mmol/l and/or 2-h plasma glucose > 11.1 mmol/l. 
Subjects with type 2 diabetes or IFG/IGT only had to meet two of the criteria, while the 
NGT had to meet 2 criteria and be insulin resistant. In women and men with IFG/IGT, 42 
and 64% were classified with MetS, while 78 and 84% with type 2 diabetes were also 
classified, respectively. Subjects with the syndrome were three times as likely to develop 
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coronary heart disease and stroke, when compared to those without the syndrome. 
Subjects identified with thesyndrome demonstrated a significant increased risk of 
cardiovascular mortality (12.0%, p<0.001) when compared to those without the 
syndrome (2.2%). 
Resnick and colleagues (26) examined insulin resistance, MetS, and risk of CVD 
in American Indians without diabetes (n=2,283). Unlike the previous study by Isomaa et 
al. (25), the researchers assessed the presence of MetS with the definition set forth by 
ATP III, and insulin resistance was determined with the homeostasis model assessment 
(HOMA). Thirty five percent of the participants met the criteria for MetS, and 
development of CVD was evident in 7.9% of total subjects during the follow-up period of 
7.9 + 1.8 yrs. The results indicated that participants with CVD were older, male, and had 
a higher systolic pressure. Rates of development of type 2 diabetes in participants with 
and without CVD after baseline were comparable. Mean baseline of HOMA-IR and MetS 
as a percentage were also similar among the two groups. Although the researchers 
concluded that HOMA-IR and MetS were both good indicators of the development of 
diabetes, neither one could predict CVD independently of other established risk factors. 
The investigators attributed this weak association with inadequate power, low occurrence 
of CVD in American Indians, small effect of insulin resistance on CVD risk factors 
(other than HDL). CVD, as a complication/risk of diabetes may also help to explain the 
weak relationship, since the sample included only non-diabetics at baseline (26). 
 The San Antonio Heart Study, conducted by Lorenzo et al. (27), compared two 
definitions (a modified version of the 1999 WHO versus ATP III) of MetS, and impaired 
glucose tolerance (IGT), to determine which was a better predictor of type 2 diabetes. 
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This epidemiological study (n=1,734), included measurements taken at baseline and at a 
follow-up time between 7 and 8 years. There was a higher sensitivity among the IGT and 
NCEP definition, in terms of predicting type 2 diabetes. The two definitions also had a 
lower positive predictive value, when compared to IGT. In conclusion, the NCEP 
definition proved to be a better predictor than the modified WHO definition. When the 
fasting glucose cutoff was lowered to 5.4 mmol/l (94 mg/dl) in the NCEP definition of 
MetS, an even more effective method of prediction of diabetes was demonstrated.  
 
Green Tea in Human Health- Observational Studies 
Green tea is derived from leaves of Camellia sinensis. Green tea is non-fermented 
and is rich polyphenols. Catechins are the primary source of polyphenols in green tea, 
with EGCG being the most predominant (48-55%), followed by EGC and ECG (both 9-
12%), and then EC 5-7% (10). Epidemiological studies in Asian countries have revealed 
that green tea may reduce the risk of death due to CVD and associated risk factors (11, 
28). The Ohsaki National Health Insurance Cohort Study, was conducted with 40,540 
Japanese adults, to explore the relationships between green tea consumption and 
mortality due to all causes and cause-specific (11). Participants were followed for up to 
11 years for all-cause mortality and up to 7 years for cause-specific mortality. Men and 
women were grouped separately and by daily green tea consumption, <1, 1-2, 3-4, and > 
5 cups/d. There was an inverse relationship between green tea consumption and 
cardiovascular mortality and all-cause mortality, with the strongest being all-cause 
mortality. The consumption of green tea and stroke mortality yielded the strongest 
inverse relationship among the different types of CVD. Although increased green tea 
 9 
consumption was associated with decreased mortality in these two areas, there was no 
reduction in mortality due to cancer.  
Another epidemiological investigation, conducted by Wu et al. (28), observed the 
relationship between habitual tea consumption, body fat percentage, and body fat 
distribution (n=1210) in a sample of Chinese males and females. Subjects were 
categorized as either habitual tea drinkers (at least 1 cup/wk for at least six months) or 
nonhabitual tea drinkers. Additional lifestyle characteristics were also obtained from the 
subjects through structured questionnaires. Bioelectrical impedance analysis (BIA) was 
used as a tool to measure body fat percentage (BF%) and waist-to-hip ratio (WHR) was 
used to assess body fat distribution. Of the sample, approximately 43% were habitual tea 
drinkers. The habitual tea drinkers were more likely to be male, current smokers, and 
habitual alcohol or coffee drinkers. The breakdown of socioeconomic status (high versus 
low) was similar for both groups, as well as age, BMI and diabetes history. Although 
many of the measures collected from this study grouped oolong, green, and black teas 
together, there was evidence to suggest an inverse relationship between habitual tea 
consumption, BF%, and body fat distribution, even more so for those who consumed tea 
regularly for more than ten years. This suggests that tea could be used to decrease and 
redistribute body fat, which could be beneficial in those with increased risk for CVD and 
diabetes, with central adiposity and obesity. 
 
Green Tea, Body Weight, Body Fat, and Clinical Parameters- Clinical Trials 
As the American population continues to see a dramatic spike in obesity and 
obesity-related diseases, the investigation of alternative treatments is crucial. The 
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potential medicinal properties of green tea have initiated many clinical trials (15,29-33). 
Green tea supplementation was recently tested for its effect on weight maintenance in 
moderately obese subjects who had already achieved mild weight loss (15). The subjects 
were first assigned to a very low energy diet for four weeks to achieve weight loss. The 
subjects were classified as either low caffeine or high caffeine consumers, and they were 
treated daily with either a green tea mixture of 270 mg EGCG and 150 mg caffeine, or 
placebo. Those receiving the green tea mixture, who consumed low levels of caffeine, 
experienced a significantly smaller amount of weight regain, when compared to the low-
caffeine placebo group and high-caffeine tea group. The low-caffeine consuming green 
tea group also had smaller increases in body mass, BMI, waist circumference (WC), and 
fat mass (FM), which was attributed to an increase in resting energy expenditure (REE). 
The concentrations of triacylglycerol and insulin were also the lowest for this group 
during the period of weight maintenance, while B-hydroxybutyrate, glycerol, and free 
fatty acids (FFAs) were increased, when compared to the other groups. This study 
proposes that the intake of a green tea caffeine mixture, along with a low caffeine diet, 
may help weight maintenance, through thermogenesis and oxidation.  
The thermogenic effects of green tea were also observed by Dulloo et al. (29). For 
this study, 10 healthy men were randomly assigned to one of three treatment groups, 
green tea extract (50 mg caffeine and 90 mg EGCG), caffeine (50 mg), and placebo, on 
three separate occasions. The participants were measured for 24-h energy expenditure 
(EE), respiratory quotient (RQ), and urinary excretion of nitrogen and catecholamines, in 
a respiratory chamber. When compared to those who received placebo, a significant 
increase in 24-h EE and a significant decrease in RQ were observed in the green tea 
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extract group. Those treated with caffeine exhibited no change in EE or RQ. This study 
suggests that green tea contains thermogenic properties greater than those of caffeine 
alone. Additional research is needed to investigate long term changes in EE with the 
consumption of green tea, and decaffeinated green tea.  
Henning et al. (30) compared the flavonol absorption and activity in plasma 8 h 
after a bolus dose of green tea, black tea, or green tea extract supplement was 
administered to 30 healthy subjects. This crossover study revealed that absorption was 
best in the subjects who consumed green tea as a supplement, and there was increased 
bioavailability of the catechins when compared to the green and black tea groups. This 
produced a small but significant increase in the antioxidant capacity. The outcomes of 
this study support the use of green tea supplements, as a possible equivalent source of 
green tea catechins as the beverage.  
 
Green Tea, Glucose, and Lipids- Clinical Trials 
Maron et al. (31) investigated the cholesterol lowering effects of a theaflavin-
enriched green tea extract on 240 adult men and women in China through a 12-week 
randomized controlled trial. Subjects had mild to moderate hypercholesterolemia, based 
on low-density lipoprotein cholesterol (LDL-C) 130-190 mg/dL, and were on a low-fat 
diet. They were randomized to receive either a green tea extract capsule or placebo 
during the intervention period. From baseline, serum total cholesterol and LDL-C 
decreased by 11.3% and 16.4%, respectively, for the green tea extract group (p<0.01). 
Although not significant, an increase in high-density lipoprotein cholesterol (HDL-C) 
was observed in the extract group (+2.3%) compared to controls (-0.7%). This study 
 12 
demonstrated that a theaflavin-enriched green tea extract may be used in conjunction with 
a low-fat diet to reduce LDL-C in subjects with mild to moderate hypercholesterolemia. 
Similarly, Erba et al. (32) found similar results after green tea supplementation (2 cups/d) 
for 42 days (n=24). Diet was controlled throughout the study. There was a moderate but 
significant decrease in LDL-C (119.9 to 106.6 mg/dL, p<0.05), when compared to 
controls. A significant increase in plasma total antioxidant activity, a significant decrease 
in plasma peroxides levels, and induced DNA oxidative damage in lymphocytes was also 
detected in the green tea group. 
A study conducted in Japan by Tsuneki et al. (33), tested the effects of green tea 
on glucose metabolism in healthy humans. The participants ingested 1.5 g of green tea 
and then underwent an OGTT. Glucose tolerance was improved with the ingestion of 
green tea, when compared to the group that received hot water. 
The effects of green tea supplementation on insulin resistance and inflammation 
were studied by Fukino et al. (34). Subjects were randomized to either the polyphenol 
supplemented group or placebo (n=66). After the two month intervention period, the 
polyphenol group had lower body weight, BMI, systolic and diastolic blood pressures, 
blood glucose level, HbA1c, insulin level and HOMA index than baseline values. 
However, there was no significant difference in change between the intervention group 
and placebo at the end of the study. Ryu et al. (35) also tested the effects of a four-week 
green tea intervention on patients with type 2 diabetes (n=55). Measurements included 
arterial stiffness, insulin resistance, blood glucose, lipid profiles, serum adiponectin 
levels, interleukin-6, and C - reactive protein. All parameters remained unchanged, 
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suggesting additional research is needed to establish mechanisms within the body that 
provide health benefits after supplementation with green tea. 
Green Tea, Glucose Metabolism, and Lipid Profiles- Animal Studies 
Tsuneki et al. (33) tested the effects of green tea on glucose metabolism in 
diabetic mice. In mice, blood glucose levels were significantly lower 2-6 hours after the 
green tea was dispensed orally. There was a distinguishable difference in lowering of 
blood glucose in the same fasting diabetic mice 2 hours after the green tea powder 
suspension was dispensed, while no significant changes were noted in their normal 
counterparts. This study proposed the idea that green tea may exert anti-diabetic effects, 
and suggested the need for further investigation of serum proteins, which could play a 
pivotal role in this mechanism.  
Another study also supported the findings that EGCG could be supplemented in 
the prevention and treatment of type 2 diabetes, after positive results were yielded from 
the addition of EGCG in rodent models of type 2 diabetes and H4IIE rat hepatoma cells 
(20). Powdered green tea as an antilipogenic agent was also tested in male Zucker rats 
(19). The rats were administered 130 mg powdered green tea, along with a high-fat diet. 
The rats in the powdered green tea group increased their body weight, at a much slower 
rate than the controls. Food consumption between the groups was recorded, and no 
differences were noted. A reduction in weight of adipose organs by about 5-9% was also 
observed, and liver weight decreased by 11%. In the plasma of the green tea fed Zucker 
rats, there was a slightly elevated triglyceride level, a significantly higher total protein, 
and a significantly lower total cholesterol, in comparison to the control rats. In the liver 
of these rats, there was a significant increase in triglyceride level, as well as a slight 
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increase in total lipid level, while total cholesterol remained unaffected. Although the 
decrease in total cholesterol may have been affected by the cholesterol-free diet, 
powdered green tea proved to have hypocholesterolemic and antilipogenic effects, 
suggesting that the powder could be a practical method used for the prevention of obesity 
and in preserving healthy tissues and organs.  
Research by Murase et al. (18) also supports the claim that tea catechins are 
responsible for weight loss on diet-induced obese mice through the stimulation of lipid 
catabolism in the liver. For this particular study, mice were fed one of three diets, low-fat, 
high-fat, or high-fat diet supplemented with tea catechins (of which 74% was identified 
as EGCG) for a period of 11 months. The mice receiving 0.2 and 0.5% catechins showed 
a noticeably lower rate of weight gain. The mice receiving the supplementation also 
exhibited lower visceral and liver fat accumulation, which could be attributed to the 
stimulation of hepatic lipid metabolism. The results indicate that supplementation with 
green tea catechins may be beneficial for those with diet-induced obesity, which could 
therefore reduce the risk of obesity related diseases, such as CVD and type 2 diabetes. 
 
In Vitro Studies 
Persson et al. (36) examined the relationship between tea and angiotensin-
converting enzyme (ACE) and nitric oxide (NO). The study used cultured endothelial 
cells from human umbilical veins (HUVEC) and incubated them for ten minutes with 
green tea, black tea, and Rooibos tea. For green tea and black tea, there was a significant 
and dose-dependent inhibition of ACE activity in the cells, while the Rooibos tea yielded 
no significant effects. Cells were also incubated with EC, EGC, ECG and EGCG for ten 
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minutes. All four tea catechins inhibited ACE activity. NO production was significantly 
increased when the cells were incubated similarly for 24 hours. This study supports the 
cardioprotective benefits of green tea on endothelial cells.  
Kanadzu et al. (37) examined the dual function of EGCG as an antioxidant and 
pro-oxidant in healthy human lymphocytes. The results indicated that bleomycin induced 





M, while it was promoted at a concentration of 10
-3
M. Although the whole 
blood lymphocytes were obtained from a healthy, non-smoking 26 year old male, 
differences in cell function from person to person must be considered. With this in mind, 
the study still supports the dual-role of EGCG as both an antioxidant and pro-oxidant in 
human lymphocytes.  
 
Body Fat Testing 
To monitor possible changes in body composition, different methods may be 
used, such as BIA, DEXA, and underwater weighing. The National Institute of Health 
released a technological statement about the use of BIA as a means for use in body 
composition measurement (38). It was determined that BIA is a practical method to 
obtain body composition because it is straightforward, noninvasive, quick, and cost-
effective. Its use is suggested in healthy individuals, mild-to moderately obese 
individuals, and those with an array of chronic conditions (except for those that may 
affect water distribution in the body). The article suggests that a 1 cm displacement of 
electrodes can result in a 2% change in resistance, which must be taken into consideration 
when assessing the changes in body fat of multiple subjects over time. Additional factors 
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that may affect the measurement include, hydration, body position, food and/or beverage 
intake, recent physical activity, and length of time body is in supine position.  
Kushner et al. (39) validated the use of BIA in obese female subjects (n=12) with 
changes in body composition during weight reduction. Of the 12 subjects, nine were 
placed on very-low-calorie diets (520 kcal/day), with or without supplemental snacks, 
while the remaining three were given a balanced hypocaloric diet (1000-1200 kcal/day). 
The subject’s body composition was measured after an overnight fast at baseline and at 
decrements of body weight of approximately 5%. Total body water was determined by 
deuterium oxide dilution (D2O), and BIA and seven-site skinfold anthropometry (SFA) 
were used to estimate body composition. The body composition analyzer used for this 
study utilized a four-surface electrode placement with subjects in the supine position with 
limbs apart. BIA and SFA were measured in triplicate, and the means were recorded. 
Significant correlations were obtained between D2O and BIA (r=0.971) and between 
D2O and SFA (r=0.932). The greater accuracy and precision made BIA a better predictor 
of fat-free mass (FFM) than SFA. The authors of this publication stressed two major 
limitations in the using BIA to predict FFM: the equations used to calculate FFM, which 
were population specific, and the assumed hydration constant of FFM. 
The Bodystat 1500, which is the machine used in this study to determine BF%, 
was used by Ghosh et al. (40) to compare its measurements with an in-house bioelectrical 
analysis machine and DEXA. The study concluded that the Bodystat 1500 was an 
inexpensive and effective tool to perform BIA. Conversely, this study was performed in 
non-obese and thin adults, unlike the population of our study (40). The Bodystat 1500 has 
been used in numerous populations, which include, but are not limited to chronic 
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obstructive pulmonary disease patients and a vast array of surgical patients (41,42). 
Although this is a quick and inexpensive method to determine BF%, additional research 
is still needed to validate this particular machine in obese subjects. 
 
3-Day Food Records 
The use of three-day food records is a pivotal measurement used in assessing 
nutrient intake in free-living subjects (43-45). Although food records have the ability to 
provide accurate information about the intake of individuals and are generally a cost 
effective tool, they have been shown to be subject to bias in several forms. For example, 
subjects do not want to be “judged” on their intake which may either influence them to 
change their eating habits, lie, or underreport actual intake. Reporting of intake may also 
be difficult for subjects who are not able to make educated guesses with regards to 
portion sizes.  
Mertz and colleagues (43) examined the use of food records in 266 male and 
female subjects, who were trained by dietitians to record their daily intake for a minimum 
of one week. Those who participated in the study were only allowed to consume food and 
drinks provided by the research center, and meals were also prepared for them for 
weekend consumption (diets were designed for subjects to maintain body weight. Of the 
266 participants, 81% estimated their average daily intake to be about 700 + 379 kcal 
(underestimated), while 8% reported an intake higher than required for maintenance by 
about 408 + 257 (overestimated). A mere 11% estimated their intake within 100 kcal of 
their actual needs. For the entire sample, there was an underestimation of intake of about 
18%.  
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Another study performed by de Vries et al. (44) also reported similar results. Pre-
experimental food records were collected from 269 non-obese subjects and mean 
reported intake was compared with required intake derived from the 6-9 week trial, where 
the food records served as a basic guide.  Adjustments to increase total caloric value of 
the meals were made throughout the study, to help the subjects maintain a consistent 
weight. This indicated a mean underestimation among all subjects of 10.4%, which was 
nearly half of the underestimation from the Mertz et al. (43). In this particular study 
women had a greater degree of underreporting than men, but men with a lower BMI 
underestimated more than their higher BMI counterparts. This was not the case for the 
women. Researchers eluded that small underestimations of intake (10.4%) could be 
attributed to the high level of education of the subjects and a small number of obese 
subjects enrolled in the study. Johnson et al. (45) discovered underreporting of energy 
intake was more prominent in a sample of older white females (56-81 y) versus older 
white males (56-78 y). There was also a direct relationship between BF% and 
underreporting of dietary intake. Therefore, tendencies of underestimation of energy 
intake must be considered when utilizing 3-day food records as a research tool to gauge 









RESEARCH DESIGN AND METHODS 
 
Subjects and Recruitment 
 This randomized clinical trial was jointly approved by the Institutional Review 
Board (IRB) at University of Oklahoma Health Sciences Center (OUHSC) and Oklahoma 
State University. Subjects were recruited through flyers and campus e-mail 
advertisements at GCRC and the Medical Center at University of Oklahoma. An initial 
telephone screening was performed prior to the screening visit and written informed 
consent was obtained from all subjects. Twenty seven subjects with MetS were enrolled 
in the study between January 2007 and 2008. According to the NCEP guidelines (24), 
MetS was defined as having any three of the following five features: waist circumference 
≥102 cm in men and ≥88 cm in women, triglycerides ≥150 mg/dL, HDL <40 mg/dL in 
men and < 50mg/dL in women, blood pressure ≥130/85 mmHg, fasting glucose 
≥100mg/dL. Eligible subjects received a history and physical examination from the 
physician on staff prior to enrollment. Adult subjects (> 21 years) with normal 
hemoglobin (Hb), white blood cells (WBC), platelets, liver, renal, and thyroid function 
tests, and on stable medications were included in the study. Subjects with any form of 
pre-existing condition (e.g. diabetes, cancer, heart disease), liver or renal disorders, or 
anemia were excluded. Participants consuming mega doses of antioxidants/fish oil 
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supplements, and/or alcohol in excess of 1 oz/day, smokers, as well as those pregnant or 
lactating were also excluded from the study. During the study period, any subjects with 
deviations from the normal range of Hb, WBC, platelets, liver enzymes, blood urea 
nitrogen (BUN), creatinine, or thyroid stimulating hormone (TSH) were dismissed.  
 
Study Design 
 This eight-week study examined the effects of green tea (4 cups/day), green tea 
supplement (2 capsules, 500 mg EGCG, 4 cups water/day), or control (4 cups water/day) 
on features of MetS (systolic and diastolic blood pressure, waist circumference, 
triglycerides, HDL, and fasting plasma glucose), body fat, hemoglobin A1C (HbA1c), and 
dietary intake in this eight-week, randomized controlled trial. Age- and sex-matched trios 
of participants with MetS were randomized to one of three groups. The principal 
investigators were blinded to participant treatment groups, but the participants were not. 
Fasting blood draws, blood pressure determination, and anthropometrics were performed 
at screening, four and eight weeks of the study. Fasting blood samples were tested for 
glucose and lipid profiles, as well as for safety parameters such as, Hb, WBC, platelets, 
and liver, renal, and thyroid function tests.  The subjects also maintained 3-day food 
records which were turned in bi-weekly at 2, 4, 6, & 8 weeks of the study. While 
participants in the control and green tea supplement groups came in for follow-up visits at 
2, 4, 6, & 8 weeks (including blood draws at 4 & 8 weeks), the green tea group made 
daily visits to the GCRC for a fresh supply of tea, to ensure compliance and consistency. 
Subjects in the green tea group consumed 2 cups of green tea in the morning at GCRC 
and were provided with another 2 cups in a container and asked to consume later in the 
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day (6-8 hours later). The Bionutrition unit at GCRC, headed by the research dietitian, 
prepared the green tea for the subjects, monitored compliance, and assisted the subjects in 
maintaining 3-day food records. Efforts were made by the bionutrition staff to limit 
interactions, specifically conversation with the green tea beverage group, that could 
potentially provide an advantage over the green tea supplement and control groups. 
Those in the control and supplement groups were provided with containers to measure 4 
cups of water to be consumed on a daily basis. Participants in the supplement group 
received a 2-week supply of capsules during their follow-up visits and we confirmed 
compliance by pill count. All qualified participants were asked to completely refrain from 
any other source of green tea or supplements other than that provided by the study, and 
maintain usual diet, physical activity and lifestyle while enrolled in the study. All 
participants were compensated during their bi-weekly follow-up visits.  
 
Green Tea and Supplements 
 Green tea bags were purchased from RC Bigelow Inc.
© 
(Fairfield, CT). Four 
decaffeinated green tea bags were steeped in 4 cups of boiled water (8 oz/cup) for 10 
minutes. No sugar or milk was added to the tea, but artificial sweetener was used 
according to the preference of the participants. The subjects consumed 2 cups at GCRC 
while being monitored, and the remaining 2 cups were provided in a container to drink 
later in the day. Participants were told not to reheat the tea which they consumed later in 
the day, but to drink it straight from the container. The subjects received 100mg of 
EGCG per cup of green tea or 400 mg EGCG per day (catechin analyses performed in the 
Human Nutrition Laboratory, OSU).  
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 Decaffeinated green tea supplements were purchased from Solaray
® 
(Park City, 
UT). The capsules were manufactured from the same lot numbers of raw materials and 
the label claimed 500 mg of green tea extract providing 250 mg of EGCG. Other 
ingredients in the capsule and filler included vegetable cellulose, magnesium stearate and 




 Anthropometric measurements were obtained by trained staff members at the 
GCRC. Height, weight, blood pressure, WC, and BF% were measured at screening, four, 
and eight-week visits. Participants removed shoes and items in pockets, and were 
weighed on a flat, uncarpeted surface with the SECA 644 Multifunctional Hand Rail 
Scale (SECA, Hamburg, Germany) and recorded to the nearest 0.1 kg.  Height was also 
measured without shoes, utilizing the Accustat Genentech Stadiometer (San Francisco, 
CA) and recorded to the nearest 0.1 cm. Systolic and diastolic blood pressure was 
collected in mmHg with Spot Vital Signs Device (Welch Allyn, Skaneateles Falls, NY). 
Waist circumference was taken from subjects at the superior iliac crest with the Gulick II 
Tape Measure (Vital Signs, Gay Mills, WI). Body fat percentage was determined through 
BIA with the Bodystat 1500 (Bodystat Ltd, Isle of Man, Great Britain).  
 
Biochemical Analyses 
 Blood samples were collected immediately after each draw at the GCRC and 
transported to the University of Oklahoma Medical Center (OUMC) Laboratory for 
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analyses of fasting glucose, lipid profile {total cholesterol, triglycerides, low-density 
lipoproteins (LDL), HDL}, and safety parameters including hemoglobin (Hb), platelets, 
WBCs, liver enzymes, creatinine, BUN, and TSH. HbA1C was analyzed at GCRC using 
DCA 2000+ (Bayer Corporation, Elkhart, IN). 
 
Dietary Analyses 
 All subjects were asked to maintain three-day food records throughout the study 
to monitor dietary changes. At the randomization visit, subjects were given instruction on 
how to maintain the record, which included visualization of portion sizes. The records 
were collected at two, four, six, and eight-week visits. Three day averages of micro and 
macronutrient intakes were analyzed using Nutritionist Pro (version 3.2, 2007, Axxya 
Systems, Stafford, TX). Reported intake of vitamin and mineral supplements were 
included in the analysis.  
 
Statistical Analyses 
 The data was first graphed to identify outliers and/or errors. The student’s t-test 
for two independent groups was applied to address any differences between groups at 
baseline. A P value of <0.05 was considered statistically significant. Initially, the subjects 
were randomized to trios by age and gender. However, due to imbalance and 
incompletion within trios, and small sample size, the data was analyzed by group. 
Changes from zero to eight weeks were assessed within groups with the paired t-test. 
Two sample t-test was applied to measure changes from zero to eight weeks between 
groups. Due to sample size, the data was not corrected for multiple hypotheses testing. 
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A total of twenty women and three men with MetS were included in the analysis 
of this study. Among the 27 subjects enrolled in the study, one withdrew due to 
relocation, one began lipid lowering medications, and two were found to be smokers. One 
subject reported emesis at week 7. The incident was reported to the IRB at the University 
of Oklahoma and the University Research Compliance at Oklahoma State University, and 
it was determined to be unrelated to the study. No other adverse events reported 
throughout the study, and compliance was maintained by all research participants.  
 
Features of MetS 
 The distribution of the features of MetS among the three groups is illustrated in 
Figure 4.1. Increased blood pressure and waist circumference and decreased levels of 
HDL cholesterol were the most common features among the three groups. The least 
prevalent feature was hyperglycemia; in controls (27%), green tea (14%), and supplement 
(20%) groups. The distribution of features was similar for controls, green tea, and green 




Baseline characteristics of the three groups, control, green tea, and green tea 
supplement, are shown in Table 4.1. No statistical differences were found at baseline 
among the three groups for weight, age, BMI, BF%, WC, SBP, DBP, fasting plasma 
glucose, HbA1c, triglycerides, total cholesterol, and HDL-C. Medication usage among the 
participants is also included in Table 4.1. This did not include dietary supplements, herbal 
remedies, or daily aspirin regimens, but did include oral contraceptives and hormone 
replacement therapies. The most common medications used included ACE-inhibitors, 
beta-blockers, and calcium-channel blockers. Medications commonly prescribed for the 
use in depression and other mental disorders were also popular forms of treatment. 
 
Anthropometric Indexes and Blood Pressure Changes 
Changes in anthropometric indexes and blood pressure measurements from 
baseline to eight weeks are depicted in Table 4.2. The change in weight and BMI were 
significantly lower in the green tea group (p<0.05), when compared to the controls. 
Weight decreased by an average of 2.5 kg and BMI by 0.9. The supplement group lost 
1.3 kg and BMI decreased by 0.4, which was not significant, but exhibited a similar 
decrease in trend as the green tea group, compared to the controls. Over the study period, 
there was a decrease in DBP in the green tea group of 4.7 mmHg. This was not 
significant when compared to the controls (p<0.1). No statistically significant differences 




Fasting Plasma Glucose, Lipid Levels, and HbA1c Changes 
Fasting plasma glucose, lipid levels, and HbA1c at baseline and eight weeks are 
represented in Table 4.3. There were no significant differences among the three groups 
for these parameters at baseline. For the green tea group, there was a slight increase in 
HDL (0.9 mg/dL; p<0.1), when compared to the controls. No statistically significant 
changes were observed for fasting plasma glucose, HbA1c, triglycerides, LDL-C, and 
total cholesterol.  
 
3-Day Food Records 
 Three-day mean intakes were calculated by group, at baseline and eight weeks. 
The changes are represented in Table 4.4. At baseline, there was a statistically significant 
difference (p<0.05) in protein and vitamin A intakes between the supplement group and 
controls (85g and 69 g of proteins,  and 2301 IU and 4309 IU of vitamin A, respectively). 
There was a significant difference in change at 8 weeks for the green tea group for 
carbohydrate intake (+67 g), when compared to the controls (-31.2 g). Although not 
significant, there was a difference in change at eight weeks in mean kilocalorie intake 
(p<0.1) between green tea (+425 kcal) and control (-178 kcal) groups. No other 
significant dietary changes between the three treatment groups were observed.  
 
Catechin Content of Green Tea Beverage and Supplement 
 The catechin content of the green tea beverage and supplement is represented in 
Table 4.5. The catechin content of the green tea beverage displayed is per cup, and 
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subjects consumed four cups daily. For the green tea supplement, content was analyzed 



























Table 4.1 Baseline characteristics of all study participants by treatment group.  
Variables Control (n=11) GT (n=7) GS (n=5) 
Female  10   6   4   
Male 1   1   1   
Weight (kg) 104.6 ± 6.9 108.6 ± 4.4 116.5 ± 8.3 
Mean age (y) 44.6 ± 3.5 44.1 ± 3.2 40 ± 2.1 
BMI (kg/m
2
) 37.4 ± 2.8 38.6 ± 1.5 41.5 ± 2.1 
Body fat (%) 45.7 ± 3.1 46.5 ± 3.1 47.7 ± 2.2 
Waist circumference (in) 43 ± 2 44.2 ± 1 49.7 ± 3.7 
Systolic blood pressure (mmHg) 129.5 ± 2.8 135.6 ± 5.9 127.4 ± 6.4 
Diastolic blood pressure (mmHg) 78.7 ± 2.1 83.7 ± 3.5 80.8 ± 2.7 
Fasting plasma glucose (mg/dL) 88.2 ± 4.1 84.7 ± 4.9 85 ± 5.3 
HbA1c (%) 5.6 ± 0.1 5.5 ± 0.1 5.4 ± 0.3 
Triglycerides (mg/dL) 121.5 ± 21.5 176.9 ± 42 148.4 ± 38.4 
Total cholesterol (mg/dL) 207.7 ± 10.6 194.3 ± 17.3 164.8 ± 22.7 
LDL-cholesterol (mg/dL) 141.1 ± 9.7 124 ± 17.6 99.4 ± 17.7 
HDL-cholesterol (mg/dL) 42.5 ± 1.9 41.4 ± 2.9 35.6 ± 3.2 
Medication users (%) 45.4   85.7   60   
Values represented as mean±standard error. 
No statistically significant differences between groups (p> 0.05). 
GT- Green tea group, GS- Green tea supplement group, BMI- Body mass index, HbA1c-











Table 4.2 Changes in anthropometric indexes and blood pressure measurements 
from zero to eight weeks in green tea beverage and supplement groups, compared 
to control group.  
 
Variables Week Control (n=11) GT (n=7) GS (n=5) 
Weight (kg) 0 104.6 ± 6.9 108.6 ± 4.4 116.5 ± 8.3 
  8 105.2 ± 6.9 106.1 ± 4 115.2 ± 7.7 
  ∆    -2.5 ± 1.2*    
BMI (kg/m
2
) 0 37.4 ± 2.8 38.6 ± 1.5 41.5 ± 2.1 
  8 37.6 ± 2.8 37.7 ± 1.4 41 ± 2 
  ∆    -0.9 ± 0.4*    
Body fat (%) 0 45.7 ± 3.1 46.5 ± 3.1 47.7 ± 2.2 
  8 45.7 ± 3.4 46.2 ± 2.6 47.5 ± 2 
Waist 0 43 ± 2 44.2 ± 1 49.7 ± 3.7 
circumference (in) 8 42.7 ± 1.8 45.2 ± 1.5 48.3 ± 3 
Systolic blood 0 129.5 ± 2.8 135.6 ± 5.9 127.4 ± 6.4 
pressure (mmHg) 8 128 ± 2.8 126.3 ± 5.3 128 ± 3.8 
Diastolic blood 0 78.7 ± 2.1 83.7 ± 3.5 80.8 ± 2.7 
pressure (mmHg) 8 80.2 ± 2.8 79 ± 3.7 81.6 ± 3.9 
Values represented as mean±standard error. 
*Changes at 8 weeks significantly different from control (p<0.05). 
GT- Green tea group, GS- Green tea supplement group, BMI- Body mass index 
 
 
Table 4.3 Changes in fasting glucose, lipids, & HbA1C from zero to eight weeks in 
green tea beverage and supplement groups, compared to control group. 
Variables Week Control (n=11) GT (n=7) GS (n=5) 
Glucose 
(mg/dL) 0 88.2 ± 4.1 84.7 ± 4.9 85.0 ± 5.3 
  8 82.5 ± 3.0 87.9 ± 3.3 76.2 ± 11.0 
HbAlc (%) 0 5.6 ± 0.1 5.5 ± 0.1 5.4 ± 0.3 
  8 5.5 ± 0.1 5.6 ± 0.2 5.4 ± 0.3 
Triglycerides 0 121.5 ± 21.5 176.9 ± 42.0 148.4 ± 38.4 
(mg/dL) 8 116.5 ± 20.5 174.4 ± 40.6 151.4 ± 36.1 
Total 
cholesterol 0 207.7 ± 10.6 194.3 ± 17.3 164.8 ± 22.7 
(mg/dL) 8 208.5 ± 9.1 199.1 ± 15.7 165.0 ± 14.5 
LDL-
cholesterol 0 141.1 ± 9.7 124.0 ± 17.6 99.4 ± 17.7 
(mg/dL) 8 144.3 ± 7.5 122.0 ± 13.1 98.6 ± 13.7 
HDL-
cholesterol 0 42.5 ± 1.9 41.4 ± 2.9 35.6 ± 3.2 
(mg/dL) 8 41.1 ± 1.6 42.3 ± 3.5 36.2 ± 4.1 
Values represented as mean±standard error. 
No statistically significant differences between groups (p> 0.05).  
GT- Green tea group, GS- Green tea supplement group, HbA1c – Hemoglobin A1C,  
LDL-low density lipoprotein, HDL- high-density lipoprotein 
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Table 4.4 Changes in dietary intake from zero to eight weeks in green tea beverage and 
supplement groups, compared to control group.  
 
Variables Week Control (n=11) GT (n=7) GS (n=5) 
Kilocalories 0 1838.8 ± 144 1724.4 ± 162.2 2034.6 ± 301.7 
 8 1660.5 ± 109 2148.9 ± 249.1 1995.2 ± 469.1 
Protein (g) 0 68.8 ± 3.6 78.4 ± 5.3 85.4 ± 4.6* 
 8 70.5 ± 5.2 86.4 ± 8 72.5 ± 12.7 
Carbohydrate (g) 0 220 ± 22.3 198.7 ± 15.7 218.9 ± 35.2 
 8 188.9 ± 15.4 266 ± 31.9 242.2 ± 67.9 
 ∆    67.4 ± 37.8†    
Total Fat (g) 0 78.3 ± 7 72.9 ± 9.6 92.1 ± 19.5 
 8 67.3 ± 4.4 85.5 ± 12.5 84.7 ± 18.6 
Cholesterol (mg) 0 239.6 ± 45 209 ± 28 291 ± 25.5 
 8 256.4 ± 38.1 240.9 ± 51.2 293.9 ± 112.5 
Saturated fat (g) 0 24.7 ± 3 23.5 ± 1.7 33.9 ± 10 
 8 23 ± 2 28.9 ± 4.7 31.1 ± 9.3 
Monounsaturated fat (g) 0 17.7 ± 1.7 16.4 ± 2.8 24.8 ± 5.9 
 8 16.1 ± 1.9 20.9 ± 4.2 15.1 ± 3.9 
Polyunsaturated fat (g) 0 10.7 ± 1 9.7 ± 2 13.4 ± 3.2 
 8 9.9 ± 1.2 12.3 ± 2.2 7.9 ± 2 
Trans fat (g) 0 1.8 ± 0.5 0.8 ± 0.3 1.9 ± 1 
 8 1.5 ± 0.4 2.2 ± 0.5 2.3 ± 1.1 
Vitamin A (IU) 0 4309.2 ± 543 4251.9 ± 849.9 2301.3 ± 484.0* 
 8 3439.7 ± 485 3229.5 ± 339.1 2248.5 ± 525.1 
Vitamin C (mg) 0 71.1 ± 33.3 50.7 ± 15.2 35.7 ± 9.8 
 8 36.4 ± 6.9 46.1 ± 19.4 41.6 ± 23 
Calcium (mg) 0 632.8 ± 72.7 760.1 ± 67.6 647.9 ± 121.3 
 8 618.3 ± 48.3 905.1 ± 157.1 715.7 ± 163.7 
Iron (mg) 0 13.5 ± 1.9 14 ± 3.9 12 ± 2.3 
 8 12.5 ± 2 14.1 ± 1.3 10.2 ± 2.3 
Vitamin E (IU) 0 3.9 ± 0.7 2.6 ± 0.8 6.3 ± 3.3 
 8 2.5 ± 0.9 4.4 ± 0.9 3.7 ± 1.1 
Dietary fiber (g) 0 15.8 ± 2 19.4 ± 2.4 13.4 ± 1.8 
 8 13.4 ± 1.5 18.2 ± 2.7 13.6 ± 3.9 
Values represented as mean±standard error. 
*Statistically different from control at baseline (p<0.05). 








Table 4.5 Catechin content of green tea beverage and supplement 
Catechin Green Tea Beverage Green Tea Supplement  
EGCG 100 mg/cup   240 mg/capsule   
EGC 22 mg/cup   52 mg/capsule   
ECG 20 mg/cup   48 mg/capsule   
EC 12 mg/cup   20 mg/capsule   
EGCG- Epigallocatechin-3 gallate, EGC- Epigallocatechin, ECG- Epicatechin 
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Features of Metabolic Syndrome





 GT- Green tea group, GS- Green tea supplement group, BP- Blood pressure, 
 WC- Waist circumference, HDL- High density lipoprotein-cholesterol,  














This is one of the first studies to test the effects of green tea supplementation in 
capsule and beverage forms on all features of MetS, collectively. In this study, subjects 
who consumed 4 cups of decaffeinated green tea beverage on a daily basis showed a 
significant decrease in total body weight and BMI, when compared to controls. A similar 
trend was observed for those in the green tea supplement group, but the change did not 
reach statistical significance. To rule out possible weight changes due to hydration status, 
the fluid intake for all three treatment groups was the same. Therefore, weight loss may 
be attributed to the effects of catechins present in the green tea beverage and supplement, 
as previously reported (17).  
 
Anthropometric Indexes and Biochemical Changes 
Previous studies have also examined the effects of caffeinated green tea on weight 
loss (15). The beverage and supplements used in our study were decaffeinated, therefore 
attributing the effects of green tea on weight loss to catechins per se and not the caffeine 
content. The lack of significant weight loss in the supplement group, suggests that the 
catechins in freshly brewed tea are more bioavailable. Nagao et al. (17) investigated the 
supplementation of green tea catechins in beverage in subjects with visceral fat-type 
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obesity (control group: n=117, high catechin group: n=123). After a 12-week 
intervention, there was a statistically significant decrease in body weight, BMI, body fat 
ratio, body fat mass, WC, hip circumference, total fat area, visceral fat area, and 
subcutaneous fat area in the high catechin group versus placebo. Average weight loss in 
subjects in this study was 1.7 kg, compared to the 2.5 kg loss in our study. Smaller 
sample size (n=23) and shorter study duration (8 wk) may possibly explain why no 
significant differences in other parameters (i.e. lipid levels, fasting plasma glucose, 
HbA1c, blood pressure, BF% and WC) were observed in our study. Although previous 
studies have detected decreases in body fat composition following green tea intervention 
with and without hypocaloric diets (15, 17, 46), BIA used in our study may not be the 
most effective method for detecting significant changes in body composition in this 
population due to confounding variables (i.e. improper alignment of electrodes, hydration 
status, and position of subject body and limbs).  
Our study findings of null effects of green tea intervention on fasting glucose and 
HbA1C may be compared to similar findings reported by MacKenzie et al. (47) and Ryu et 
al. (35) who did not find any differences in HbA1C  following a 3-month supplementation 
of green and black tea extracts in adults with type 2 diabetes mellitus or in fasting glucose 
levels following green tea intake for 4 weeks in type 2 diabetes patients, respectively. 
However, Fukino et al. (34) reported a significant reduction in HbA1C levels in 
individuals with borderline diabetes following a 2-month supplementation of green tea 
catechins. Significant results may not have been duplicated in our study based on a 




The increase in reported intake of kilocalories and carbohydrate by the green tea 
group may be explained by the results of a previous study which tested black, green, and 
mulberry tea extracts on carbohydrate and triacylglycerol absorption in healthy 
volunteers (n= 20). Consumption of the mixed tea extract
 
resulted in a highly significant 
increase in breath-hydrogen
 
concentrations, indicative of carbohydrate malabsorption 
(48). Malabsorption of carbohydrate may lead to additional intake of carbohydrate to 
compensate for losses. This could possibly explain the increase in carbohydrate intake, 
with a significant decrease in body weight in the green tea group as a result of caloric 
content of malabsorbed carbohydrate being unavailable for weight gain. 
 
Limitations 
 Human subjects are generally the optimal model for real-life application.  
However, in working with a population that cannot be fully controlled, limits in clinical 
research arise. Although compliance was measured in the form of pill counts and the 
monitoring of green tea consumption, there was no way to monitor subject adherence 
away from the research center. Physical activity was not monitored, and there could have 
been lifestyle changes made by the subjects, even though they were instructed to maintain 
their typical daily activities.  
Due to a high percentage of subjects on stable medications, especially for the 
control blood pressure, benefits of supplementation may have been masked. 
Combinations of medications may have had additional affects on parameters tested. 
Middeke et al. (49) investigated the effects of antihypertensive combination therapies in 
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humans. There were significant increases in both groups for triglycerides (p < 0.05). 
HDL-C decreased significantly (p < 0.001 and < 0.05) in both groups, while LDL-C 
increased significantly (p < 0.05) in the sotalol group. Fasting plasma glucose and HbA1c 
increased significantly (p < 0.05) in the sotalol combination group, but similar results 
were not observed for the captopril combination group. The long term use (one year) of a 
diuretic and beta-blocker combination had adverse effects on the metabolism of lipids 
and glucose. However, the diuretic/ACE-inhibitor combinations resulted in less 
pronounced effects on lipid metabolism, and no adverse effects were observed on the 
metabolism of glucose. This combination of drug therapy had significant effects on 
parameters, like the variables tested in this study. This article suggests that combinations 
of medication use may have effects on metabolism, which must also be considered. 
Small sample size and short study duration may account for trends that did not 
reach levels of significance.  
 
Implications for Future Practice and Research 
In summary, this trial confirmed that daily consumption of 4 cups of 
decaffeinated green tea beverage may be a beneficial tool for weight loss and may help 
lower DBP and increase HDL, without lifestyle modifications. Furthermore, 
improvements in these parameters may also help decrease risks of CVD and type II 
diabetes. Additional research in the area of green tea extract supplements is also needed 
to support its use for similar purposes, and to possibly explain the trends observed in the 
green tea supplement group in this study. Due to the high usage of medications by 
participants in our study, future studies should focus on green tea catechin 
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supplementation in subjects with or without stable medications. Further research which 
explains the mechanisms which may cause weight loss with increased carbohydrate 
intake may also be beneficial to the field of study. Additionally, more significant results 
may have been achieved with longer study duration and larger sample size.  
 
Hypotheses 
1)  We reject the null hypothesis: Daily consumption of green tea beverage or EGCG 
supplements will have no significant effect on anthropometric measures in participants 
with MetS. (Change in body weight & BMI, when compared to controls; p<0.05) 
2) We fail to reject the null hypothesis: Daily consumption of green tea beverage or 
EGCG supplements will have no significant effect on glucose and lipid parameters in 
participants with MetS. 
3) We reject the null hypothesis: Daily consumption of green tea beverage or EGCG 
supplements will have no significant effect on dietary intake in participants with 
MetS.(Change in carbohydrate intake, when compared to controls; p<0.05) 
 
Conclusions 
 Thus, it can be concluded that daily supplementation of decaffeinated green tea 
beverage may be beneficial for weight loss in at risk subjects, as it was shown to decrease 
body weight and BMI significantly, when compared to controls. Although the 
intervention groups did not reach statistical significance for HDL, an increase in trend 
was observed, when compared to controls. Similarly, a decrease in trend in DBP was 
evident in the green tea beverage group. It is possible that other clinical parameters could 
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reach statistical significance through additional clinical trials with larger sample sizes and 
longer study duration. Health benefits associated with green tea consumption could 
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Scope and Method of Study:  Green tea, rich in flavonoids, has been shown to possess 
cardiovascular health benefits. This is a randomized controlled trial investigating whether 
green tea beverage or extract supplementation improved the cardiovascular risk profile 
associated with metabolic syndrome (MetS). Subjects with MetS were matched for age 
and sex and were randomly assigned to control (4 cups water/day), green tea (4 
cups/day), or green tea supplement (2 capsules & 4 cups water/day) group for 8 weeks. 
Fasting blood samples, anthropometric measurements, and 3-day food records were taken 
at screening, 4 & 8 weeks. Blood samples were analyzed for lipid and glucose levels 
using standard clinical chemistry techniques. Dietary data were analyzed for nutritional 
content using Nutritionist Pro, version 3.2.  
 
Findings and Conclusions:  Daily supplementation of decaffeinated green tea (4 
cups/day) may be beneficial to humans diagnosed with the metabolic syndrome (MetS), 
as it may help decrease total body weight. Body weight and BMI decreased significantly 
(p<0.05) in green tea (-2.5 kg and -0.9, respectively) versus control (+0.6 kg and + 0.2 
kg) at eight weeks. Although the supplement group did not reach significance, a similar 
weight loss trend was observed (-1.3 kg), which also decreased BMI (-0.4). When 
compared to controls, there were no significant differences in change at eight weeks for 
the green tea beverage or supplement group in fasting plasma glucose levels, lipid levels, 
body fat percentage, waist circumference, or blood pressure. However, a decrease in 
trend (p<0.1) of diastolic blood pressure at eight weeks for the green tea group (-4.7 
mmHg) compared to placebo (+1.5 mmHg) was noted, and the same trend did not exist 
for the supplement group. An increase in trend (p<0.1) was observed for HDL cholesterol 
in green tea (+0.9 mg/dL) versus control (-1.4 mg/dL). A similar pattern was true for the 
supplement group (+0.6 mg/dL). At eight weeks, carbohydrate intake was significantly 
higher (p<0.05) for the green tea group (+67 g) versus control (-31 g). The supplement 
group exhibited a similar trend, (+24 g), suggesting possible carbohydrate malabsorption 
in both the green beverage and supplement groups. Thus, green tea beverage or 
supplements may be a beneficial tool to aid weight loss. Additional research, including 
longer study duration and larger sample size, is needed to confirm benefits such as a 
decrease in diastolic blood pressure and increase in HDL cholesterol with green tea 
flavonoid supplementation. 
